Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial
2017; Elsevier BV; Volume: 18; Issue: 4 Linguagem: Inglês
10.1016/s1470-2045(17)30168-7
ISSN1474-5488
AutoresKim N., Celestia S. Higano, Brent A. Blumenstein, Jean‐Marc Ferrero, James A. Reeves, Susan Feyerabend, Gwénaëlle Gravis, Axel S. Merseburger, Arnulf Stenzl, Andries M. Bergman, Som D. Mukherjee, Paweł Zalewski, Fred Saad, Cindy Jacobs, Martin Gleave, Johann S. de Bono,
Tópico(s)Nuclear Structure and Function
Referência(s)